Cargando…

The Role of Adipose Tissue in the Pathogenesis and Therapeutic Outcomes of Inflammatory Bowel Disease

Though historically regarded as an inert energy store, adipose tissue is a complex endocrine organ, which is increasingly implicated in the pathogenesis of inflammatory bowel disease (IBD). Accumulating evidence points to visceral adipose tissue and specifically to its mesenteric component, or “cree...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eder, Piotr, Adler, Maciej, Dobrowolska, Agnieszka, Kamhieh-Milz, Julian, Witowski, Janusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627060/ https://www.ncbi.nlm.nih.gov/pubmed/31234447 http://dx.doi.org/10.3390/cells8060628

Ejemplares similares

Dietary Support in Elderly Patients with Inflammatory Bowel Disease
por: Eder, Piotr, et al.
Publicado: (2019)

IL-17 in Peritoneal Dialysis-Associated Inflammation and Angiogenesis: Conclusions and Perspectives
por: Witowski, Janusz, et al.
Publicado: (2018)

Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease
por: Nijakowski, Kacper, et al.
Publicado: (2021)

A Vicious Cycle of Osteosarcopenia in Inflammatory Bowel Diseases—Aetiology, Clinical Implications and Therapeutic Perspectives
por: Skrzypczak, Dorota, et al.
Publicado: (2021)

Oxidative Stress Is Predominant in Female but Not in Male Patients with Autoimmune Thrombocytopenia
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014)

Position statement of the Polish Society of Gastroenterology and the National Gastroenterology Consultant on vaccination against COVID-19 among patients with inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2021)

How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions
por: Eder, Piotr, et al.
Publicado: (2021)

Iron Deficiency Anemia in Inflammatory Bowel Diseases—A Narrative Review
por: Mahadea, Dagmara, et al.
Publicado: (2021)

The position statement of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology regarding the management of patients with inflammatory bowel disease during the COVID-19 pandemic
por: Łodyga, Michał, et al.
Publicado: (2020)

What Links an Increased Cardiovascular Risk and Inflammatory Bowel Disease? A Narrative Review
por: Łykowska-Szuber, Liliana, et al.
Publicado: (2021)

Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response
por: Catar, Rusan, et al.
Publicado: (2021)

Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells
por: Catar, Rusan, et al.
Publicado: (2022)

Is there a relation between vitamin D, interleukin-17, and bone mineral density in patients with inflammatory bowel disease?
por: Krela-Kazmierczak, Iwona, et al.
Publicado: (2018)

Alterations in programmed cell death mechanism and their role in the pathogenesis of inflammatory bowel diseases
por: Eder, Piotr, et al.
Publicado: (2014)

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease
por: Rychter, Anna Maria, et al.
Publicado: (2021)

The introduction of the IBD Disk in Poland – a new tool for assessing disability in patients with inflammatory bowel disease
por: Eder, Piotr, et al.
Publicado: (2019)

Social Distancing during COVID-19 Pandemic among Inflammatory Bowel Disease Patients
por: Łodyga, Michał, et al.
Publicado: (2021)

Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy
por: Catar, Rusan Ali, et al.
Publicado: (2022)

Role of Adipose Tissue in Inflammatory Bowel Disease
por: Karaskova, Eva, et al.
Publicado: (2021)

The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease
por: Zuo, Tao, et al.
Publicado: (2018)

Role of Obesity, Mesenteric Adipose Tissue, and Adipokines in Inflammatory Bowel Diseases
por: Bilski, Jan, et al.
Publicado: (2019)

New pharmaceuticals in inflammatory bowel disease
por: Łodyga, Michał, et al.
Publicado: (2015)

Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases
por: Ratajczak, Alicja Ewa, et al.
Publicado: (2020)

Differentially Expressed MicroRNAs in Maternal Plasma for the Noninvasive Prenatal Diagnosis of Down Syndrome (Trisomy 21)
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014)

Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism
por: Zhao, Hongfan, et al.
Publicado: (2023)

Adipokines and the role of visceral adipose tissue in inflammatory bowel disease
por: Karrasch, Thomas, et al.
Publicado: (2016)

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
por: Moll, Guido, et al.
Publicado: (2020)

Role of inflammatory factors and adipose tissue in pathogenesis of rheumatoid arthritis and osteoarthritis. Part I: Rheumatoid adipose tissue
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention
por: Sewell, Gavin W, et al.
Publicado: (2022)

Cytokines in Spondyloarthritis and Inflammatory Bowel Diseases: From Pathogenesis to Therapeutic Implications
por: Felice, Carla, et al.
Publicado: (2023)

Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling
por: Catar, Rusan, et al.
Publicado: (2021)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Human adipose tissue accumulation is associated with pro-inflammatory changes in subcutaneous rather than visceral adipose tissue
por: Lesna, I Kralova, et al.
Publicado: (2017)

Impact of Cigarette Smoking on the Risk of Osteoporosis in Inflammatory Bowel Diseases
por: Ratajczak, Alicja Ewa, et al.
Publicado: (2021)

NGS study of glucocorticoid response genes in inflammatory bowel disease patients
por: Skrzypczak-Zielinska, Marzena, et al.
Publicado: (2019)

Where Do We Stand in the Behavioral Pathogenesis of Inflammatory Bowel Disease? The Western Dietary Pattern and Microbiota—A Narrative Review
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2022)

Role of ferroptosis in the pathogenesis and as a therapeutic target of inflammatory bowel disease (Review)
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2023)

Immunological pathogenesis of inflammatory bowel disease
por: Lee, Seung Hoon, et al.
Publicado: (2018)

Does Folic Acid Protect Patients with Inflammatory Bowel Disease from Complications?
por: Ratajczak, Alicja Ewa, et al.
Publicado: (2021)

Mesenchymal Stromal Cell Therapeutic Delivery: Translational Challenges to Clinical Application
por: Caplan, Henry, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ht621vkqahc2fqaqse4d35n1gs